Amneal Pharmaceuticals to set up 2 new manufacturing facilities in India

Amneal Pharmaceuticals, a top pharmaceutical company, announced plans to spend up to USD 200 million (approximately Rs 1,680 crore) in India within the next four to five years on constructing two new manufacturing plants in Ahmedabad. The company announced that it plans to build two new facilities, one for peptide synthesis and one for advanced sterile fill-finish manufacturing.

"In this latest expansion in India, Amneal will make a total net investment of between USD 150 million and USD 200 million over the next four to five years to build two new greenfield facilities...," it said.

Commenting on the development, Amneal Pharmaceuticals Co-Founders and Co-Chief Executive Officers Chirag Patel and Chintu Patel said, "With these new facilities, we are proud to be at the forefront of developing and manufacturing innovative, branded medicines at scale in India, which will supply the local market and the rest of the world."

The business that commenced activities in India in 2008 now operates eight manufacturing facilities, with five located in Ahmedabad, and also has sites in Dahej, Hyderabad, and Vizag, as well as offices in Mumbai. Over the last decade, around USD 600 million has been put into investments in India.

The company stated that these facilities together can manufacture around 60 million injectables and 8.5 billion tablets every year.